The Nicobyt gum is a scientifically developed solution to reduce cravings for nicotine, the addictive substance in tobacco, and alleviate withdrawal symptoms.
Nicobyt gum
Smoking remains one of India’s most pressing health challenges, contributing to 1.35 million deaths annually. As the world’s second-largest consumer and producer of tobacco, the country faces a significant public health crisis. In response, Micro Labs, a trusted name in pharmaceuticals and the manufacturer of Dolo, has launched Nicobyt Nicotine Sugar-Free Gums under its wellness division, Micro Wellness, to support individuals in quitting smoking and leading healthier lives.
ADVERTISEMENT
The Nicobyt gum is a scientifically developed solution to reduce cravings for nicotine, the addictive substance in tobacco, and alleviate withdrawal symptoms. It is most effective when combined with a structured stop-smoking program, enabling individuals to reclaim control over their health and well- being. The company has launched the sugar-free gums along with the “Quitting is Winning”, a rigorously tested and scientifically backed 12-week program designed to help individuals quit smoking effectively. Manufactured in a WHO-approved facility, Nicobyt adheres to the highest international standards of safety, quality, and efficacy.
“Our scientifically backed program provides individuals with the tools and support they need to quit smoking and improve their overall quality of life,” said Ms. Diya Surana, Head of Strategy, Digital Transformation, and OTC Wellness at Micro Labs. “Through Nicobyt and our ‘Quitting is Winning’ campaign, we aim to transform lives and foster a healthier, smoke-free future for India.”
The company plans to take this campaign nationwide, using a multi-pronged approach to spread hope and inspire individuals to embrace a smoke-free life, fostering a movement for change across the country.
The global nicotine gum market was valued at USD 1.63 billion in 2023 and is projected to grow to USD 2.55 billion by 2032. In India, the market was estimated at USD 33.09 million in 2023, with a forecasted value of USD 75.74 million by 2030.
“Our efforts go beyond selling products; we are building a movement that resonates with people in every corner of the country, making quitting smoking a proud and celebrated choice,” said Mr. Dilip Surana, Chairman and Managing Director of Micro Labs.
“While we are creating this movement, we also aim to carve a niche in the emerging wellness sector. Micro Labs has always prioritised the health of Indians, and this program will be another significant milestone in our commitment to improving lives.”
Disclaimer:Mid-Day holds no responsibility or liability for any direct, indirect, implied, punitive, special, incidental, or consequential damages resulting directly or indirectly from the use of this content. It is advisable to seek guidance from an expert advisor or health professional as the information on the site is not a substitute for professional medical advice, diagnosis, or treatment. The information provided should not be used for diagnosing or treating a health problem or disease, and individuals seeking personal medical advice should consult with a licensed physician. The views and opinions expressed are those of the sponsor/author/agency and do not represent the stance or views of Mid-Day. Any purchases made from the branded segment are at your own discretion and risk.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
